<DOC>
	<DOCNO>NCT01100840</DOCNO>
	<brief_summary>The purpose study : 1 . To characterize type frequency molecular alteration epidermal growth factor receptor ( EGFR ) pathway , FGFR4 EML-ALK Asian patient non-small cell lung cancer 2 . To identify candidate biomarkers importance EGFR estrogen pathways Most , , human malignancy include lung cancer cause somatic alteration genome , lead activation oncogene inactivation tumor suppressor gene resultant oncogenic effect . In addition mutation , increase chromosomal copy number ( amplification polysomy ) DNA methylation mechanism oncogene activation tumour suppressor gene inactivation respectively . Little known relationship oncogene EGFR family recently describe oncogene FGFR4 fusion gene EML4-ALK . Recent data suggest molecularly define subgroup non-small cell lung cancer ( NSCLC ) exist use predict sensitivity target agent ( erlotinib gefitinib ) cytotoxic chemotherapy ( pemetrexate , gemcitabine , platinum agent ) . The finding estrogen receptor present lung tumour estrogen stimulate growth proliferation lung cancer vitro vivo provocative . Further study evaluate role estrogen sex hormone lung cancer warrant . A understanding molecular indicator lung cancer prognosis treatment prediction would improve drug development patient treatment selection . Archived paraffin-embedded fresh frozen NSCLC tumor tissue obtain via Department Pathology National University Tissue Repository respectively . Clinico-pathological characteristic obtain case record , Pathology Tissue Repository . DNA isolate use standard technique . Sequencing gene EGFR signal pathway : EGFR , KRAS , ErbB2 , ErbB3 , MET , PI3K , BRAF well FGFR4 . Unstained slides paraffin-embedded tissue obtain subject fluoresce vitro hybridization ( FISH ) breakpoints EML4 ALK gene previously describe . For case snap-frozen , RNA extract EML4-ALK fusion confirm use RT-PCR pre-specified primer . To analyse expression protein putative relevance EGFR function ( EGFR , ErbB2 , ErbB3 , AKT , MET , STAT , ERK , MAPK , cyclin D1 , C/EBPa ) , downstream effect EGFR : cell proliferation ( Ki-67 ) , angiogenesis ( CD34 , VEGF-A ) , apoptosis ( bcl-2 ) , metastasis , hormonal influence ( oestrogen progesterone receptor , aromatase ) , TMA technology utilise . The status tumor suppressor gene PTEN C/EBPa analyse .</brief_summary>
	<brief_title>A Retrospective Study Biomarkers Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria />
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>